Xinhua news agency reported that China began to conduct clinical trials ofVaccines once morest COVID-19 mutant Omicron species On Sunday, May 1, last It is a lethal vaccine. This trial is an official clinical trial in Hangzhou. East China’s Zhejiang Province
The volunteers were given the vaccine at Sulan Hospital (Hangzhou) following passing relevant examinations, consent, basic medical examinations. blood sample collection, etc.
Vaccines once morest the virusOmicron species This new dead species Developed by China National Biotech Group (CNBG), a subsidiary of Sino Farm, it has been approved by the China National Pharmaceutical Administration. to conduct a clinical trial on April 26
